Tocagen Inc (TOCA)

TOCA Chart

Catalysts

News and Press Releases

We searched over 50 sources and couldn't find any news or press releases related to Tocagen.

Here are some articles we think you might like.

• Innoviva Acquires AstraZeneca-Spin Off At $2.20/Share

  Benzinga | May 23rd

  AZNINVA
• Why Kala Pharmaceuticals Shares Are Rising Today

  Benzinga | May 23rd

  KALA
• Windtree Presents Data from its Positive SEISMiC Phase 2 Study of Istaroxime in Early Cardiogenic Shock in a Late-Breaker Presentation at the European Society of Cardiology Heart Failure Meeting in Ma

  GlobeNewsWire | May 23rd

  WINT
• SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Natera, Inc. with Losses of $100,000 to Contact the Firm

  Newsfile Corp | May 23rd

  NTRA
• Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Reminds AbbVie, Inc. Investors of Deadline in Securities Fraud Class Action Lawsuit and Encourages Investors to Contact the Firm

  Newsfile Corp | May 23rd

  ABBV
• Why Inovio Pharmaceuticals Stock Is Rising Today

  Benzinga | May 23rd

  INO
• Accelerate Diagnostics to Participate in 42nd Annual William Blair Growth Stock Conference on June 7, 2022

  PRNewsWire | May 23rd

  AXDX
• 22nd Century Group (Nasdaq: XXII) Announces John J. Miller Joins Its Tobacco Business

  GlobeNewsWire | May 23rd

  XXII
• Kessler Topaz Meltzer & Checker, LLP: July 11, 2022 Deadline Reminder for Oscar Health, Inc. Investors - OSCR

  Newsfile Corp | May 23rd

  OSCR
• Why SIGA Technologies Stock Is Surging

  Benzinga | May 23rd

  SIGA
• Praxis Precision Medicines Adds Global Business Expertise to Board of Directors with Appointment of Jill DeSimone

  GlobeNewsWire | May 23rd

  PRAX
• FDA Removes Clinical Hold On Ocugen's COVID Vaccine Trial

  Benzinga | May 23rd

  OCGN
• Pfizer's Three-Dose Covid Vaccine Is 80% Effective in Young Children, Data Show

  Barrons | May 23rd

  PFE
• ImmunityBio Submits Biologics License Application for N-803 Plus BCG for Patients with BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma in Situ

  Business Wire | May 23rd

  IBRX
• Neurocrine Biosciences Presents New INGREZZA® (valbenazine) Data on Tardive Dyskinesia Improvement and Stability of Psychiatric Symptoms at American Psychiatric Association Annual Meeting 2022

  PRNewsWire | May 23rd

  NBIX

Company Info